| Active ingredient (INN) | Dinoprostone |
|---|---|
| Brand names | Prostin E2 Vaginal Gel, Minprostin E2 Vaginaltabletten |
| ATC level 5 | G02AD02 |
| ATC level 4 | G02AD |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Pfizer Australia Pty Ltd, FERRING PHARMACEUTICALS LIMITED, Ferring Pharmaceuticals Pty Ltd |
| Registrations on file | 4 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Prostin E2 Vaginal Gel | 1mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| Prostin E2 Vaginal Gel | 2mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| DINOPROSTONE | — | dinoprostone | 🇬🇧 GB | FERRING PHARMACEUTICALS LIMITED | Active |
| CERVIDIL dinoprostone | 10 mg | — | 🇦🇺 AU | Ferring Pharmaceuticals Pty Ltd | Active |